Cellular Immunotherapy to Treat Leukemia and Lymphomas
One of the first cellular immunotherapies for leukemia and non-Hodgkin lymphomas is about to hit the market. Early results suggest that it may be able to cure these diseases, even in their advanced stages.

Cleveland Clinic experts predict that 2017 will be the year that this groundbreaking treatment is presented to the FDA for treatment of acute lymphoblastic leukemia (ALL) — potentially triggering a wave of approvals for other blood cancers....